VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
32 hedge funds and large institutions have $583K invested in Viracta Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 11 closing their positions.
Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
6
Increased
5
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VF
1
Virtu Financial
New York
|
$21K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$262K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$15K |
4 |
4
Jane Street
New York
|
$8.92K |
5 |
5
Renaissance Technologies
New York
|
$46.1K |